Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 970417

Products of advanced glycotionin patients with type 2 diabetes and vascular desease


Turk Z.; Šesto M.; Sklodar J.; Ferenčak G.; Pokupec R.; Turk N.; Stavljenić Rukavina A.:
Products of advanced glycotionin patients with type 2 diabetes and vascular desease // Annals of clinical biochemistry, 40 (2003), 5; 552-559 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 970417 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Products of advanced glycotionin patients with type 2 diabetes and vascular desease

Autori
Turk Z. ; Šesto M. ; Sklodar J. ; Ferenčak G. ; Pokupec R. ; Turk N. ; Stavljenić Rukavina A.:

Izvornik
Annals of clinical biochemistry (0004-5632) 40 (2003), 5; 552-559

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
advanced glycation ; type 2 diabetes ; vascular disease

Sažetak
Background: Non-enzymatic glycation leading to advanced glycation endproduct (AGE) formation is thought to contribute to vascular pathology. In the present study, AGEs and anti-AGE antibodies in free and immune complex-bound form were assayed in the serum of diabetic (DMCAD) (n = 69) and nondiabetic (n = 78) patients with coronary artery disease (CAD) and in control subjects (n = 47) free from vascular disease. Methods: A blocking enzyme-linked immunosorbent assay (ELISA) was used to test immunoreactivity against AGE epitope(s) and a competitive ELISA was used to measure total AGE content. Results: Anti-AGE immunoreactivity was significantly higher in diabetic than in control subjects (P = 0.045). Although a wide range of anti-AGE antibody titres were observed in nondiabetic CAD patients, there was no significant difference from those of control subjects. Both diabetic and nondiabetic CAD patients had a higher concentration of circulating immune complexes containing the AGE moiety as antigen than did control subjects (DMCAD versus control, P = 0.041 ; CAD versus control, P = 0.047). Study patients showed a positive correlation between serum AGE and AGE- immune complexes (DM, r = 0.29, P = 0.014 ; CAD, r = 0.26, P = 0.019), whereas no such correlation was recorded in controls (r = 0.08, P = 0.89). Conclusion: To our knowledge, this is the first study demonstrating increased AGE- immune complexes in patients with CAD, either with or without diabetes, suggesting that AGE- immune complexes might be involved in the atherosclerotic process, either as the result of it or as part of the pathophysiologic process.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove:
Klinika za dijabetes, endokrinologiju i bolesti metabolizma Vuk Vrhovac,
Sveučilište Libertas


Citiraj ovu publikaciju:

Turk Z.; Šesto M.; Sklodar J.; Ferenčak G.; Pokupec R.; Turk N.; Stavljenić Rukavina A.:
Products of advanced glycotionin patients with type 2 diabetes and vascular desease // Annals of clinical biochemistry, 40 (2003), 5; 552-559 (međunarodna recenzija, članak, znanstveni)
Turk Z., Šesto M., Sklodar J., Ferenčak G., Pokupec R., Turk N. & Stavljenić Rukavina A.: (2003) Products of advanced glycotionin patients with type 2 diabetes and vascular desease. Annals of clinical biochemistry, 40 (5), 552-559.
@article{article, year = {2003}, pages = {552-559}, keywords = {advanced glycation, type 2 diabetes, vascular disease}, journal = {Annals of clinical biochemistry}, volume = {40}, number = {5}, issn = {0004-5632}, title = {Products of advanced glycotionin patients with type 2 diabetes and vascular desease}, keyword = {advanced glycation, type 2 diabetes, vascular disease} }
@article{article, year = {2003}, pages = {552-559}, keywords = {advanced glycation, type 2 diabetes, vascular disease}, journal = {Annals of clinical biochemistry}, volume = {40}, number = {5}, issn = {0004-5632}, title = {Products of advanced glycotionin patients with type 2 diabetes and vascular desease}, keyword = {advanced glycation, type 2 diabetes, vascular disease} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE





Contrast
Increase Font
Decrease Font
Dyslexic Font